£77.89

Springer Clinically Relevant Resistance in Cancer Chemotherapy: 112 (Cancer Treatment and Research, 112)

Price data last checked 11 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£78 today · previous high £78 · all-time low £78

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 80 days · 80 data points (no recent data)

Historical
Generating forecast…
£77.89 £77.88 £77.88 £77.88 £77.89 £77.89 £77.89 28 June 2026 17 July 2026 06 August 2026 26 August 2026 15 September 2026

Price Distribution

Price distribution over 80 days • 1 price levels

Days at Price
80 days 0 20 40 60 80 £78 Days at Price

Price Analysis

Most common price: £78 (80 days, 100.0%)

Price range: £78 - £78

Price levels: 1 different prices over 80 days

Description

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
23 October 2012
Listed Since
03 March 2013

Barcode

No barcode data available

Similar Products You Might Like

Drug Resistance in the Treatment of Cancer (Cancer: Clinical Science in Practice)
85% match

Drug Resistance in the Treatment of Cancer (Cancer: Clinical Science in Practice)

Cambridge University Press

£164.35 15 Sep 2026
Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells
84% match

Molecular and Cellular Biology of Multidrug Resistance in Tumour Cells

Springer

£67.00 18 Aug 2026
Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)
83% match

Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Springer

£166.32 31 Aug 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
82% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 06 Aug 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
82% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 05 Aug 2026
Cancer Drug Resistance Research Perspectives
82% match

Cancer Drug Resistance Research Perspectives

£14.98 18 Aug 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
82% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£166.02 07 Aug 2026
Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)
81% match

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Springer

£108.01 05 Aug 2026
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)
81% match

Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)

Springer

£108.01 05 Aug 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
81% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 12 Aug 2026
Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)
81% match

Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)

Springer

£113.93 07 Aug 2026
Current Cancer Therapeutics
80% match

Current Cancer Therapeutics

Springer

£72.12 30 Jul 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
79% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£76.42 06 Aug 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
79% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 08 Aug 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
79% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 05 Aug 2026
Breast Cancer Chemosensitivity: 608 (Advances in Experimental Medicine and Biology, 608)
79% match

Breast Cancer Chemosensitivity: 608 (Advances in Experimental Medicine and Biology, 608)

Springer

£92.50 14 Sep 2026
Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide
79% match

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Springer

£84.04 04 Aug 2026
Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
79% match

Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology

Springer

£113.73 29 Jul 2026
Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)
79% match

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Springer

£112.42 13 Sep 2026
Molecular Targeted Therapy of Lung Cancer
79% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026
Precision Medicine in Cancer Therapy: 178 (Cancer Treatment and Research, 178)
79% match

Precision Medicine in Cancer Therapy: 178 (Cancer Treatment and Research, 178)

Springer

£88.21 17 Aug 2026
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)
79% match

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Springer

£141.08 30 Aug 2026
Pharmaceutical Perspectives of Cancer Therapeutics
79% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 08 Aug 2026
Metronomic Chemotherapy: Pharmacology and Clinical Applications
79% match

Metronomic Chemotherapy: Pharmacology and Clinical Applications

Springer

£81.78 06 Aug 2026